Australia markets closed

Vita Life Sciences Limited (VLS.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
2.2400-0.0600 (-2.61%)
At close: 11:35AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 346.96%
S&P500 52-week change 322.55%
52-week high 32.4700
52-week low 31.5650
50-day moving average 32.2169
200-day moving average 32.0825

Share statistics

Avg vol (3-month) 31.14k
Avg vol (10-day) 3509
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 821.25M
% held by insiders 174.16%
% held by institutions 15.98%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.09
Trailing annual dividend yield 33.91%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 12.24%
Operating margin (ttm)16.53%

Management effectiveness

Return on assets (ttm)13.29%
Return on equity (ttm)22.74%

Income statement

Revenue (ttm)74.16M
Revenue per share (ttm)1.38
Quarterly revenue growth (yoy)15.60%
Gross profit (ttm)N/A
EBITDA 12.1M
Net income avi to common (ttm)9.08M
Diluted EPS (ttm)0.1560
Quarterly earnings growth (yoy)48.30%

Balance sheet

Total cash (mrq)24.63M
Total cash per share (mrq)0.44
Total debt (mrq)387k
Total debt/equity (mrq)0.89%
Current ratio (mrq)2.98
Book value per share (mrq)0.77

Cash flow statement

Operating cash flow (ttm)12.98M
Levered free cash flow (ttm)11.17M